The neural cell adhesion molecule (NCAM) is a membrane-associated member of the immunoglobulin superfamily capable of both homophilic and heterophilic binding. To investigate the significance of this binding, a gene targeting strategy in embryonic stem (ES) cells was used to replace the membrane-associated forms of NCAM with a soluble, secreted form of its extracellular domain. Although the heterozygous mutant ES cells were able to generate low coat color chimeric mice, only the wild-type allele was transmitted, suggesting the possibility of dominant lethality. Analysis of chimeric embryos with high level of ES cell contribution revealed severe growth retardation and morphological defects by E8.5-E9.5. The second allele was also targeted, and embryos derived almost entirely from the homozygous mutant ES cells exhibited the same lethal phenotype as observed with heterozygous chimeras. Together, these results indicate that dominant lethality associated with the secreted NCAM does not require the presence of membrane-associated NCAM. Furthermore, the data indicate that potent bioactive cues or signals can be generated by NCAM.The neural cell adhesion molecule (NCAM) is a membranebound immunoglobulin superfamily glycoprotein that plays a role in cell-cell and cell-matrix adhesion through both its homophilic and heterophilic binding activity (1). Targeted mutations in the Ncam gene have been produced in embryonic stem (ES) cells to generate mutant mice in which the in vivo function of NCAM can be evaluated. The first two animals generated, a null mutation and a deletion of one of the major NCAM isoforms, were both viable and fertile, with no phenotype evident by casual observation (2, 3). However, more intensive analysis revealed localized and distinct defects in the central nervous system including the morphology of the subventricular zone, olfactory bulb, cerebellum, retina, and hippocampus (3). Other aspects of the phenotype remain to be discovered and studied, but also are likely to represent localized alterations in tissue structure.In this study we employed the same genetic approach to a different purpose, namely to examine the effects of NCAMbinding events through the generation of a soluble and secreted form of the extracellular domain of the molecule. Furthermore, the use of homologous recombination to generate the secreted form has provided the opportunity to examine these effects in the absence of the membraneassociated forms. The findings indicate that abnormal NCAM expression is capable of generating drastic malformations that were not apparent from either the null or the NCAM180 isoform mutations (2, 3).
MATERIALS AND METHODS
Construction of Targeting